ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $225,410 | -26.3% | 1,265 | -31.8% | 0.00% | -100.0% |
| Q1 2023 | $305,835 | -4.3% | 1,854 | -8.6% | 0.00% | 0.0% |
| Q4 2022 | $319,527 | -19.3% | 2,029 | -22.8% | 0.00% | 0.0% |
| Q3 2022 | $396,000 | -10.6% | 2,628 | -2.4% | 0.00% | 0.0% |
| Q2 2022 | $443,000 | -41.4% | 2,692 | -20.7% | 0.00% | 0.0% |
| Q1 2022 | $756,000 | -10.6% | 3,394 | -4.7% | 0.00% | 0.0% |
| Q4 2021 | $846,000 | +19.2% | 3,563 | +17.0% | 0.00% | 0.0% |
| Q3 2021 | $710,000 | +1.1% | 3,044 | -10.9% | 0.00% | 0.0% |
| Q2 2021 | $702,000 | +10.6% | 3,415 | +10.5% | 0.00% | 0.0% |
| Q1 2021 | $635,000 | +2.1% | 3,090 | +6.6% | 0.00% | 0.0% |
| Q4 2020 | $622,000 | +11.7% | 2,898 | -5.0% | 0.00% | 0.0% |
| Q3 2020 | $557,000 | -73.3% | 3,050 | -73.0% | 0.00% | -80.0% |
| Q2 2020 | $2,083,000 | -40.6% | 11,302 | -35.0% | 0.01% | -44.4% |
| Q1 2020 | $3,506,000 | +2.4% | 17,378 | -5.0% | 0.01% | +28.6% |
| Q4 2019 | $3,423,000 | – | 18,299 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |